Specialized hormone optimization clinics for men’s testosterone replacement therapy (TRT) and women’s bioidentical hormone replacement therapy (BHRT) operate under strict regulatory scrutiny. Because testosterone is a DEA Schedule III controlled substance, clinics must adhere to stringent prescribing protocols, documented clinical necessity, and regular laboratory surveillance to prevent cardiovascular and hematologic complications. Furthermore, non-physician entrepreneurs need compliant MSO structures to partner lawfully with medical providers. Access Plus Health provides board-certified endocrinologists, urologists, and family medicine physicians who serve as dedicated Medical Directors and prescribing clinicians. We furnish standardized clinical treatment algorithms, including baseline hormone panel requirements, PSA and hematocrit monitoring benchmarks, and titration protocols. Our nationwide network empowers your hormone clinic to serve in-person and telehealth patients across all 50 states while remaining fully compliant with state medical boards, federal controlled substance acts, and CPOM regulations.